naproxen (IP 890)
/ Iroko
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
December 13, 2023
Investigation of Gold Nanoparticle Naproxen-Derived Conjugations in Ovarian Cancer.
(PubMed, ACS Mater Au)
- "The proposed system demonstrated an increased chemotherapeutic effect than the free drug counterparts with at least 5 times lower IC50 values. NDC@AuNP nanosystems induced higher apoptosis rates, which established a simple and novel way to investigate activity of prospective drugs in drug discovery research."
Journal • Oncology • Ovarian Cancer • Solid Tumor • PTGS2
May 14, 2023
Evaluating ionic liquids for its potential as eco-friendly solvents for naproxen removal from water sources using COSMO-RS: Computational and experimental validation.
(PubMed, Environ Res)
- "This research will contribute easy designing of ionic liquid-based separation technologies for naproxen. In different separation technologies, ionic liquids can be employed as extractants, carriers, adsorbents, and absorbents."
Journal
April 06, 2023
Anti-Balamuthia mandrillaris and anti-Naegleria fowleri effects of drugs conjugated with various nanostructures.
(PubMed, Arch Microbiol)
- "Furthermore, Sulfamethoxazole and Naproxen significantly diminished host cell death caused by B. mandrillaris by up to 70% (p < 0.05), while Amphotericin B-, Sulfamethoxazole-, Metronidazole-based drug nanoconjugates showed the highest reduction in host cell death caused by N. fowleri by up to 80%. When tested alone, all of the drug nanoconjugates tested in this study showed limited toxic effects against human cells in vitro (less than 20%). Although these are promising findings, prospective work is warranted to comprehend the mechanistic details of nanoconjugates versus amoebae as well as their in vivo testing, to develop antimicrobials against the devastating infections caused by these parasites."
Journal • Infectious Disease
March 19, 2020
Coronavirus pandemic update 40: Ibuprofen and COVID-19 (are NSAIDs safe?), trials of HIV medications
(YouTube)
- "Controversy surrounding the use of NSAID medications like ibuprofen and naproxen with COVID-19 infection have heightened now that the French government has issued warnings against them. Dr. Seheult also discusses preliminary fatality data in the United States released by the CDC, and the results of a novel coronavirus treatment trial with HIV medications Lopinavir and Ritonavir in hospitalized COVID-19 patients."
Video
June 16, 2019
Electrostatic Precipitation of Submicron Particles in a Molten Carrier.
(PubMed, Pharmaceutics)
- "The newly developed melt electrostatic precipitator was able to collect isolated naproxen particles in a molten carrier. A solid naproxen xylitol dispersion was prepared, which showed a reduction of the dissolution time by 82%, and a release of 80% of the total drug, compared to the physical mixture."
Journal
May 27, 2019
IMPROVEMENT SOLUBILITY OF AMPHIPHILIC NAPROXEN-NIOSOME FOR INFLAMMATORY ARTHRITIS TREATMENT
(EULAR 2019)
- "Niosomal formulation has been evaluated as a safe drug delivery system. In this study, we showed that niosomal naproxen has more stability and more efficiently affect the cells. It can be explained by increasing the bioavailability of naproxen by niosomal nanocarriers which probably is based on more water solubility and more efficient cell entrance of drug."
1 to 6
Of
6
Go to page
1